Psychiatric (axis I) and personality (axis II) disorders in patients with burning mouth syndrome or atypical facial pain

Scandinavian Journal of Pain

Volumn 2, Issue 4, 2011, Pages 155-160

  Taiminen, Tero ^a   Kuusalo, Laura ^a   Lehtinen, Laura ^a   Forssell, Heli ^a   Hagelberg, Nora ^a   Tenovuo, Olli ^a   Luutonen, Sinikka ^a   Pertovaara, Antti ^b   Jääskeläinen, Satu ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Atypical facial pain; Burning mouth syndrome; Chronic pain; Persistent idiopathic facial pain; Personality disorder; Psychiatric disorder

Indexed keywords

ADULT; AGED; ALCOHOLISM; ARTICLE; ATYPICAL FACIAL PAIN; AVOIDANT PERSONALITY DISORDER; BIPOLAR I DISORDER; BURNING MOUTH SYNDROME; CHRONIC PAIN; CLINICAL EVALUATION; COMORBIDITY; COMPULSIVE PERSONALITY DISORDER; DEPENDENT PERSONALITY DISORDER; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; EMOTION; EYELID REFLEX; FACE PAIN; FEAR; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; NEUROPHYSIOLOGY; NEUROSIS; PANIC; PERSONALITY DISORDER; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; SOCIAL PHOBIA; SPECIFIC PHOBIA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TYPE A BEHAVIOR; TYPE B BEHAVIOR;

EID: 80053161004     PISSN: 18778860     EISSN: 18778879     Source Type: Journal    
DOI: 10.1016/j.sjpain.2011.06.004     Document Type: Article

References (76)

1. Woda A., Pionchon P. A unified concept of idiopathic orofacial pain: clinical features. J Orofac Pain 1999, 13:172-184.
2. Woda A., Tubert-Jeannin S., Bouhassira D., Attal N., Fleiter B., Goulet J.-P., Gremeau-Richard C., Navez M.L., Picard P., Pionchon P., Albuisson E. Towards a new taxonomy of idiopathic orofacial pain. Pain 2005, 116:396-406.
3. Bergdahl M., Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999, 28:350-354.
4. Scala A., Checchi L., Montevecchi M., Marini I. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003, 14:275-291.
5. Bergdahl J., Anneroth G. Burning mouth syndrome: literature review and model for research and management. J Oral Pathol Med 1993, 22:433-438.
6. Lipton J.A., Ship J.A., Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Den Assoc 1993, 124:115-121.
7. Forssell H., Tenovuo O., Silvoniemi P., Jääskeläinen S. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Neurology 2007, 69:1451-1459.
8. Jääskeläinen S.K., Rinne J.O., Forssell H., Tenovuo O., Kaasinen V., Sonninen P., Bergman J. Role of dopaminergic system in chronic pain-a fluorodopa-PET study. Pain 2001, 90:257-260.
9. Hagelberg N., Forssell H., Aalto S., Rinne J.O., Scheinin H., Taiminen T., Aalto S., Luutonen S., Någren K., Jääskeläinen S. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 2003, 101:149-154.
10. Hagelberg N., Forssell H., Aalto S., Rinne J.O., Scheinin H., Taiminen T., Någren K., Eskola O., Jääskeläinen S.K. Altered dopamine D2 receptor binding in atypical facial pain. Pain 2003, 106:43-48.
11. Derbyshire S.W.G., Jones A.K.P., Devani P., Friston K.J., Feinman C., Harris M., Pearce S., Watson J.D., Frackowiak R.S. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. J Neurol Neurosurg Psychiatry 1994, 57:1166-1172.
12. Albuquerque R.J.C., de Leeuw R., Carlson C.R., Okeson J.P., Miller C.S., Andersen A.H. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain 2006, 122:223-234.
13. Forssell H., Jääskeläinen S., Tenovuo O., Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002, 99:41-47.
14. Lauria G., Majorana A., Borgna M., Lombardi R., Penza P., Padovani A., et al. Trigeminal small-fibre sensory neuropathy causes burning mouth syndrome. Pain 2005, 115:332-337.
15. Yilmaz Z., Renton T., Yiangou Y., Zakrzewska J., Chessell I.P., Bountra C., Anand P. Burning mouth syndrome as a trigeminal small fibre neuropathy: increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci 2007, 14:864-871.
16. Greméau-Richard C., Dubray C., Aublet-Cuvelier B., Ughetto S., Woda A. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized controlled trial. Pain 2010, 149:27-32.
17. Gilpin S.F. Glossodynia. JAMA 1936, 106:1722-1724.
18. Lascelles R.G. Atypical facial pain and depression. Br J Psychiatry 1966, 112:651-659.
19. Feinmann C., Harris M., Cawley R. Psychogenic facial pain: presentation and treatment. BMJ 1984, 288:436-438.
20. Ott G., Ott C. Glossodynia-psychodynamic basis and results of psychopathometric investigations. J Psychosomatic Res 1992, 36:677-686.
21. Remick R.A., Blasberg B., Campos P.E., Miles J.E. Psychiatric disorders associated with atypical facial pain. Can J Psychiatry 1983, 28:178-181.
22. Rojo L., Silvestre F.J., Bagan J.V., De Vicente T. Psychiatric morbidity in burning mouth syndrome. Psychiatric interview versus depression and anxiety scales. Oral Surg Oral Med Oral Pathol 1993, 75:308-311.
23. Rojo L., Silvestre F.J., Bagan J.V. Prevalence of psychopathology in burning mouth syndrome. A comparative study among patients with and without psychiatric disorders and controls. Oral Surg Oral Med Oral Pathol 1994, 73:312-316.
24. Bogetto F., Maina G., Ferro G., Carbone M., Gandolfo S. Psychiatric comorbidity in patients with burning mouth syndrome. Psychosom Med 1998, 60:378-385.
25. Nicholson M., Wilkinson G., Field E., Longman L., Fitzgerald B. A pilot study: stability of psychiatric diagnoses over 6 months in burning mouth syndrome. J Psychosom Res 2000, 49:1-2.
26. Lang E., Kaltenhäuser M., Seidler S., Mattenklodt P., Neundörfer B. Persistent idiopathic facial pain exists independent of somatosensory input from the painful region: findings from quantitative sensory functions and somatotopy of the primary somatosensory cortex. Pain 2005, 118:80-91.
27. Solomon S., Lipton R.B. Atypical facial pain: a review. Semin Neurol 1988, 8:332-338.
28. Gouda J.J., Brown J.A. Atypical facial pain and other pain syndromes. Neurosurg Clin North Am 1997, 8:87-100.
29. Bergdahl J., Anneroth G., Perris H. Personality characteristics of patients with resistant burning mouth syndrome. Acta Odontol Scand 1995, 53:7-11.
30. Trikkas G., Nikolatou O., Samara C., Bazopoulou-Kyrkanodou E., Rabavilas A.D., Christodoulou G.N. Glossodynia: personality characteristics and psychopathology. Psychother Psychosom 1996, 65:163-168.
31. Maina G., Albert U., Gandolfo S., Vitalucci A., Bogetto F. Personality disorders in patients with burning mouth syndrome. J Personal Disord 2005, 19:84-93.
32. Jääskeläinen S.K., Forssell H., Tenovuo O. Electrophysiological testing of the trigeminofacial system: aid in the diagnosis of atypical facial pain. Pain 1999, 80:191-200.
33. Diagnostic and statistical manual of mental disorders (DSM-IV) 1994, APA, Washington, DC. 4th ed. American Psychiatric Association (Ed.).
34. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders (SCID-I, 4/97 version) 1997, Biometrics Research Department, New York State Psychiatric Institute, New York, NY.
35. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W., Benjamin L. Structured clinical interview for DSM-IV axis II disorders (SCID-II) 1997, Biometrics Research Department, New York State Psychiatric Institute, New York, NY.
36. Kessler R.C., Chiu W.T., Demler O., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:617-627.
37. Kessler R.C., Berglund P., Demler O., Jin R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602.
38. Pirkola S.P., Isometsä E., Suvisaari J., Aro H., Joukamaa M., Poikolainen K., Koskinen S., Aromaa A., Lönnqvist J. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population: results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 2005, 40:1-10.
39. Lenzenweger M.F., Lane M.C., Loranger A.W., Kessler R.C. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007, 62:553-564.
40. Lamey P.-J., Lamb A.B. Prospective study of aetiological factors in burning mouth syndrome. BMJ 1988, 296:1243-1246.
41. Reich J., Nduaguba M., Yates W. Age and sex distribution of DCM III personality cluster traits in a community population. Compr Psychiatry 1988, 29:298-303.
42. Uguz F., Cicek E., Salli A., Karahan A.Y., Albayrak I., Kaya N., Ugurlu H. Axis I and II psychiatric disorders in patients with fibromyalgia. Gen Hosp Psychiatry 2010, 32:105-107.
43. Ohayon M.M., Scatzberg A.F. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 2003, 60:39-47.
44. Türp J.C., Kowalski C.J., O'Leary N., Stohler C.S. Pain maps from facial pain patients indicate a broad pain geography. J Dent Res 1998, 77:1465-1472.
45. Dersh J., Polatin P.B., Gatchel R.J. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med 2002, 64:773-786.
46. Diatchenko L., Nackley A.G., Slade G.D., Fillingim R.B., Maixner W. Idiopathic pain disorders-pathways of vulnerability. Pain 2006, 123:226-230.
47. Jääskeläinen S.K., Forssell H., Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain 1997, 73:455-460.
48. 158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299:1240-1243.
49. Wood P.B. Stress and dopamine: implications for the pathophysiology of chronic widespread pain. Med Hypothesis 2004, 62:420-424.
50. Strigo I.A., Simmons A.N., Matthews S.C., Craig A.D., Paulus M.P. Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain. Arch Gen Psychiatry 1998, 65:1275-1284.
51. Borsook D., Becerra L., Carlezon W.A., Shaw M., Renshaw P., Elman I., Levine J. Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders. Eur J Pain 2007, 11:7-20.
52. Tiihonen J., Kuikka J., Bergström K., Lepola U., Koponen H., Leinonen E. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 1997, 154:239-242.
53. Lambert G., Johansson M., Ågren H., Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness. Arch Gen Psychiatry 2000, 57:787-793.
54. 2 receptor binding potential in social phobia. Am J Psychiatry 2000, 157:457-459.
55. Klimek V., Schenck J.E., Han H., Stockmeier C.A., Ordway G.A. Dopaminergic abnormalities in amygdaloid nuclei in major depression: a post-mortem study. Biol Psychiatry 2002, 52:740-748.
56. Meyer J.H., Ginovart N., Boovariwala A., Sagrati S., Hussey D., Garcia A., Young T., Praschak-Rieder N., Wilson A.A., Houele S. Elevated monoamine oxidase A levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 2006, 63:1209-1216.
57. 1 receptor binding in the striatum of patients with obsessive-compulsive disorder. J Affect Disord 2009, 114:321-326.
58. 2 dopamine dysfunction in drug-naïve obsessive-compulsive disorder. Neuroimage 2008, 42:306-314.
59. Tomer R., Aharon-Petez J. Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency. J Neurol Neurosurg Psychiatry 2004, 75:972-975.
60. Conrad R., Schilling G., Bausch C., Nadstawek J., Wartenberg H.C., Wegener I., Geiser F., Imbierowicz K., Liedtke R. Temperament and character personality profiles and personality disorders in chronic pain patients. Pain 2007, 133:197-209.
61. Nyman E.S., Loukola A., Varolo T., Ekelund J., Veijola J., Joukamaa M., Taanila A., Pouta A., Miettunen J., Freimer N., Järvelin M.-R., Peltonen L. Impact of the dopamine receptor gene family on temperament traits in a population-based cohort. Am J Med Genet B Neuropsychiatr Genet 2009, 150:854-865.
62. Zald D.H., Cowan R.L., Riccardi P., Baldwin R.M., Ansari M.S., Li R., Shelby E.S., Smith C.E., McHugo M., Kessler R.M. Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans. J Neurosci 2008, 28:14372-14378.
63. Hess C., Reif A., Strobel A., Boreatti-Hümmer A., Heine M., Lesch K.-P., Jacop C.P. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm 2009, 116:121-130.
64. Defazio G., Bearardelli A., Fabbrini G., Martino D., Fincati E., Fiaschi A., Moretto G., Abbruzzese G., Marchese R., Bonuccelli U., Del Dotto P., Barone P., De Vivo E., Albanese A., Antonini A., Canesi M., Lopiano L., Zibetti M., Nappi G., Martignoni E., Lamberti P., Tinazzi M. Pain as a nonmotor symptom of Parkinson disease. Arch Neurol 2008, 65:1191-1194.
65. 2 receptors in the dorsolateral striatum. Brain Res 2000, 855:260-266.
66. Hagelberg N., Jääskeläinen S.K., Martikainen I.K., Mansikka H., Forssell H., Scheinin H., Hietala J., Pertovaara A. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol 2004, 500:187-192.
67. Burkey A.R., Carstens E., Jasmin L. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci 1999, 19:4169-4179.
68. Wood P.B., Schweinhardt P., Jaeger E., Dagher A., Hakyemez H., Rabiner E.A., Bushnell M.C., Chizh B.A. Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 2007, 25:3576-3582.
69. Wood P.B., Patterson J.C., Sunderland J.J., Tainter K.H., Glabus M.F., Lilien D.L. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 2007, 8:51-58.
70. Scherman D., Desnos C., Darchen F., Pollack P., Javoy-Agid F., Agid Y. Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol 1989, 26:551-557.
71. Rinne J.O., Hietala J., Ruotsalainen U., Saki E., Laihnen A., Någren K., Lehikoinen P., Oikonen V., Syvälahti E. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C] raclopride. J Cereb Blood Flow Metab 1993, 13:310-314.
72. Bäckman L., Ginovart N., Dixon R.A., Robins Wahlin T.-B., Wahlin Å., Halldin C., Farde L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am J Psychiatry 2000, 157:635-637.
73. 2 receptor binding characteristics in vivo. Am J Psychiatry 1998, 155:768-773.
74. 2-like receptors in the human brain. Am J Psychiatry 2001, 158:308-311.
75. Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 1994, 5:27-42.
76. Koponen S., Taiminen T., Portin R., Himanen L., Isoniemi H., Heinonen H., Hinkka S., Tenovuo O. Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study. Am J Psychiatry 2002, 159:1315-1321.